2,4-Dichlorothiazole → (S)-methyl 2-(tert-butoxycarbonyl)-3-(4-chlorothiazol-2-yl)propanoate

HRID 20030

반응식

HRID 20030 반응식
[C:1]([O:5][C:6]([C@H:8]([CH2:13]I)[C:9]([O:11][CH3:12])=[O:10])=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl[C:16]1[S:17][CH:18]=[C:19]([Cl:21])[N:20]=1>>[C:1]([O:5][C:6]([C@@H:8]([CH2:13][C:16]1[S:17][CH:18]=[C:19]([Cl:21])[N:20]=1)[C:9]([O:11][CH3:12])=[O:10])=[O:7])([CH3:4])([CH3:3])[CH3:2]

참가 물질

3

실험 절차

The title compound was synthesized in a manner analogous to that described Example 475, using (R)-methyl 2-(tert-butoxycarbonyl)-3-iodopropanoate and 2,4-dichlorothiazole (prepared according to Reynaud, Pierre; Robba, Max; Moreau, Robert C; New synthesis of the thiazole ring; Bulletin de la Societe Chimique de France (1962), 1735-8). MS m/z: 321 (23%, M+1), 265.0 (100%, M−55.1).

후처리

  1. customprepared
  2. customNew synthesis of the thiazole ring

출처 및 근거

ORD 기록
ord-64d1d7ba6333472782ac0a3b90a1e555
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07745484B2

연결된 노트

불러오는 중…